These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21232871)

  • 21. Dynamics of Fasciola hepatica transmission in the Andean Patagonian valleys, Argentina.
    Kleiman F; Pietrokovsky S; Prepelitchi L; Carbajo AE; Wisnivesky-Colli C
    Vet Parasitol; 2007 Apr; 145(3-4):274-86. PubMed ID: 17270347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological studies of Fasciola gigantica infections in cattle in the highveld and lowveld communal grazing areas of Zimbabwe.
    Pfukenyi DM; Mukaratirwa S; Willingham AL; Monrad J
    Onderstepoort J Vet Res; 2006 Mar; 73(1):37-51. PubMed ID: 16715877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
    Mottier L; Alvarez L; Fairweather I; Lanusse C
    J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
    Mezo M; González-Warleta M; Carro C; Ubeira FM
    J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.
    Craig TM; Huey RL
    Am J Vet Res; 1984 Aug; 45(8):1644-5. PubMed ID: 6476577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The fasciolosis epizootic situation in Russia].
    Gorokhov VV; Molchanov IA; Maĭsheva-Kolesnikova MA; Gorokhova EV
    Med Parazitol (Mosk); 2011; (3):55-9. PubMed ID: 21932550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns in size and shedding of Fasciola hepatica eggs by naturally and experimentally infected murid rodents.
    Valero MA; Panova M; Comes AM; Fons R; Mas-Coma S
    J Parasitol; 2002 Apr; 88(2):308-13. PubMed ID: 12054003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a benzenedisulfonamide against experimental Fasciola hepatica infections in calves.
    Wyckoff JH; Bradley RE
    Am J Vet Res; 1983 Nov; 44(11):2203-4. PubMed ID: 6650967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immature liver fluke infection in winter and spring.
    Bartram D; Taylor M
    Vet Rec; 2013 Jan; 172(3):82. PubMed ID: 23335687
    [No Abstract]   [Full Text] [Related]  

  • 33. Seasonal transmission of Fasciola hepatica to cattle in northwestern United States.
    Hoover RC; Lincoln SD; Hall RF; Wescott R
    J Am Vet Med Assoc; 1984 Mar; 184(6):695-8. PubMed ID: 6144660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of Fasciola hepatica towards hexachlorophene.
    Dorsman W
    Wiad Parazytol; 1968; 14(5):631-8. PubMed ID: 5753155
    [No Abstract]   [Full Text] [Related]  

  • 35. Providing information about triclabendazole resistance status influences farmers to change liver fluke control practices.
    Coyne LA; Bellet C; Latham SM; Williams D
    Vet Rec; 2020 Oct; 187(9):357. PubMed ID: 32719082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
    Maes L; Vanparijs O; Lauwers H; Deckers W
    Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field trial on comparative efficacy of four fasciolicides against natural liver fluke infection in cattle.
    Elitok B; Elitok OM; Kabu M
    Vet Parasitol; 2006 Feb; 135(3-4):279-85. PubMed ID: 16289862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle.
    Ibarra F; Vera Y; Quiroz H; Cantó J; Castillo R; Hernández A; Ochoa P
    Vet Parasitol; 2004 Feb; 120(1-2):65-74. PubMed ID: 15019144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human fascioliasis and the presence of hybrid/introgressed forms of Fasciola hepatica and Fasciola gigantica in Vietnam.
    Le TH; De NV; Agatsuma T; Thi Nguyen TG; Nguyen QD; McManus DP; Blair D
    Int J Parasitol; 2008 May; 38(6):725-30. PubMed ID: 18031748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathological changes of liver in infection of Fasciola hepatica].
    Gajewska A; Smaga-Kozłowska K; Wiśniewski M
    Wiad Parazytol; 2005; 51(2):115-23. PubMed ID: 16838620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.